カテゴリ： QYResearch, 世界, 医療/バイオ

ボルチオキセチン臭化水素酸塩錠の世界市場2025年：5mg、10mg、20mg

■ 英語タイトル：Global Vortioxetine Hydrobromide Tablets Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8924）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8924
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ボルチオキセチン臭化水素酸塩錠の世界市場2025年：5mg、10mg、20mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はボルチオキセチン臭化水素酸塩錠のグローバル市場について調査・分析し、世界のボルチオキセチン臭化水素酸塩錠市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（5mg、10mg、20mg）、用途別セグメント分析（抗うつ薬、抗不安薬）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、H.Lundbeck A/S、Kanghong Pharmaceutical、Takeda Pharmaceuticals USA、Takeda Pharmaceutical、Zydus Pharms、CSPC Ouyi Pharmaceutical、Brilliant Pharmaceutical、Chiatai Tianqing、Sino Biopharmaceuticalなどが含まれています。ボルチオキセチン臭化水素酸塩錠のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、ボルチオキセチン臭化水素酸塩錠市場規模を算出する際に考慮しました。

・ボルチオキセチン臭化水素酸塩錠市場の概要
- 製品の定義
- ボルチオキセチン臭化水素酸塩錠の種類別セグメント
- 世界のボルチオキセチン臭化水素酸塩錠市場規模：タイプ別分析（5mg、10mg、20mg）
- ボルチオキセチン臭化水素酸塩錠の用途別セグメント
- 世界のボルチオキセチン臭化水素酸塩錠市場規模：用途別分析（抗うつ薬、抗不安薬）
- 世界のボルチオキセチン臭化水素酸塩錠市場規模予測（2020年-2031年）
- ボルチオキセチン臭化水素酸塩錠の平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ボルチオキセチン臭化水素酸塩錠市場の競争状況およびトレンド

・ボルチオキセチン臭化水素酸塩錠の地域別市場規模
- 北米のボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- 米国のボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- ヨーロッパのボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- アジア太平洋のボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- 中国のボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- 日本のボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- 韓国のボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- インドのボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- オーストラリアのボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- 中南米のボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）
- 中東・アフリカのボルチオキセチン臭化水素酸塩錠市場規模（2020年-2031年）

・種類別セグメント：5mg、10mg、20mg
- 世界のボルチオキセチン臭化水素酸塩錠のタイプ別販売量（2020年-2025年）
- 世界のボルチオキセチン臭化水素酸塩錠のタイプ別売上（2020年-2025年）
- 世界のボルチオキセチン臭化水素酸塩錠のタイプ別価格

・用途別セグメント：抗うつ薬、抗不安薬
- 世界のボルチオキセチン臭化水素酸塩錠の用途別販売量（2020年-2025年）
- 世界のボルチオキセチン臭化水素酸塩錠の用途別売上（2020年-2025年）
- 世界のボルチオキセチン臭化水素酸塩錠の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
H.Lundbeck A/S、Kanghong Pharmaceutical、Takeda Pharmaceuticals USA、Takeda Pharmaceutical、Zydus Pharms、CSPC Ouyi Pharmaceutical、Brilliant Pharmaceutical、Chiatai Tianqing、Sino Biopharmaceutical

・産業チェーンと販売チャネルの分析
- ボルチオキセチン臭化水素酸塩錠産業チェーン分析
- ボルチオキセチン臭化水素酸塩錠の主要原材料
- ボルチオキセチン臭化水素酸塩錠の販売チャネル
- ボルチオキセチン臭化水素酸塩錠のディストリビューター
- ボルチオキセチン臭化水素酸塩錠の主要顧客

・ボルチオキセチン臭化水素酸塩錠市場ダイナミクス
- ボルチオキセチン臭化水素酸塩錠の業界動向
- ボルチオキセチン臭化水素酸塩錠市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Vortioxetine Hydrobromide Tablets market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Vortioxetine Hydrobromide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Vortioxetine Hydrobromide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of Vortioxetine Hydrobromide Tablets include H.Lundbeck A/S, Kanghong Pharmaceutical, Takeda Pharmaceuticals USA, Takeda Pharmaceutical, Zydus Pharms, CSPC Ouyi Pharmaceutical, Brilliant Pharmaceutical, Chiatai Tianqing and Sino Biopharmaceutical, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vortioxetine Hydrobromide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vortioxetine Hydrobromide Tablets.
The Vortioxetine Hydrobromide Tablets market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vortioxetine Hydrobromide Tablets market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vortioxetine Hydrobromide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
H.Lundbeck A/S
Kanghong Pharmaceutical
Takeda Pharmaceuticals USA
Takeda Pharmaceutical
Zydus Pharms
CSPC Ouyi Pharmaceutical
Brilliant Pharmaceutical
Chiatai Tianqing
Sino Biopharmaceutical
Segment by Type
5mg
10mg
20mg
Segment by Application
Antidepressants
Anxiolytics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vortioxetine Hydrobromide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vortioxetine Hydrobromide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Vortioxetine Hydrobromide Tablets Market Overview
1.1 Product Overview and Scope of Vortioxetine Hydrobromide Tablets
1.2 Vortioxetine Hydrobromide Tablets Segment by Type
1.2.1 Global Vortioxetine Hydrobromide Tablets Market Value Comparison by Type (2025-2031)
1.2.2 5mg
1.2.3 10mg
1.2.4 20mg
1.3 Vortioxetine Hydrobromide Tablets Segment by Application
1.3.1 Global Vortioxetine Hydrobromide Tablets Market Value by Application: (2025-2031)
1.3.2 Antidepressants
1.3.3 Anxiolytics
1.4 Global Vortioxetine Hydrobromide Tablets Market Size Estimates and Forecasts
1.4.1 Global Vortioxetine Hydrobromide Tablets Revenue 2020-2031
1.4.2 Global Vortioxetine Hydrobromide Tablets Sales 2020-2031
1.4.3 Global Vortioxetine Hydrobromide Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vortioxetine Hydrobromide Tablets Market Competition by Manufacturers
2.1 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vortioxetine Hydrobromide Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Vortioxetine Hydrobromide Tablets Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Product Type & Application
2.7 Vortioxetine Hydrobromide Tablets Market Competitive Situation and Trends
2.7.1 Vortioxetine Hydrobromide Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vortioxetine Hydrobromide Tablets Players Market Share by Revenue
2.7.3 Global Vortioxetine Hydrobromide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vortioxetine Hydrobromide Tablets Retrospective Market Scenario by Region
3.1 Global Vortioxetine Hydrobromide Tablets Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global Vortioxetine Hydrobromide Tablets Global Vortioxetine Hydrobromide Tablets Sales by Region: 2020-2031
3.2.1 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2020-2025
3.2.2 Global Vortioxetine Hydrobromide Tablets Sales by Region: 2026-2031
3.3 Global Vortioxetine Hydrobromide Tablets Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2020-2031
3.3.1 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2020-2025
3.3.2 Global Vortioxetine Hydrobromide Tablets Revenue by Region: 2026-2031
3.4 North America Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.4.1 North America Vortioxetine Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.4.3 North America Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.5.1 Europe Vortioxetine Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.5.3 Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Vortioxetine Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.6.3 Asia Pacific Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.7.1 Latin America Vortioxetine Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.7.3 Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vortioxetine Hydrobromide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Vortioxetine Hydrobromide Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vortioxetine Hydrobromide Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vortioxetine Hydrobromide Tablets Sales by Type (2020-2031)
4.1.1 Global Vortioxetine Hydrobromide Tablets Sales by Type (2020-2025)
4.1.2 Global Vortioxetine Hydrobromide Tablets Sales by Type (2026-2031)
4.1.3 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2020-2031)
4.2 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2020-2031)
4.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2020-2025)
4.2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Type (2026-2031)
4.2.3 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Vortioxetine Hydrobromide Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vortioxetine Hydrobromide Tablets Sales by Application (2020-2031)
5.1.1 Global Vortioxetine Hydrobromide Tablets Sales by Application (2020-2025)
5.1.2 Global Vortioxetine Hydrobromide Tablets Sales by Application (2026-2031)
5.1.3 Global Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2020-2031)
5.2 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2020-2031)
5.2.1 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2020-2025)
5.2.2 Global Vortioxetine Hydrobromide Tablets Revenue by Application (2026-2031)
5.2.3 Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Vortioxetine Hydrobromide Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 H.Lundbeck A/S
6.1.1 H.Lundbeck A/S Corporation Information
6.1.2 H.Lundbeck A/S Description and Business Overview
6.1.3 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Product Portfolio
6.1.5 H.Lundbeck A/S Recent Developments/Updates
6.2 Kanghong Pharmaceutical
6.2.1 Kanghong Pharmaceutical Corporation Information
6.2.2 Kanghong Pharmaceutical Description and Business Overview
6.2.3 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.2.5 Kanghong Pharmaceutical Recent Developments/Updates
6.3 Takeda Pharmaceuticals USA
6.3.1 Takeda Pharmaceuticals USA Corporation Information
6.3.2 Takeda Pharmaceuticals USA Description and Business Overview
6.3.3 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Product Portfolio
6.3.5 Takeda Pharmaceuticals USA Recent Developments/Updates
6.4 Takeda Pharmaceutical
6.4.1 Takeda Pharmaceutical Corporation Information
6.4.2 Takeda Pharmaceutical Description and Business Overview
6.4.3 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.4.5 Takeda Pharmaceutical Recent Developments/Updates
6.5 Zydus Pharms
6.5.1 Zydus Pharms Corporation Information
6.5.2 Zydus Pharms Description and Business Overview
6.5.3 Zydus Pharms Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zydus Pharms Vortioxetine Hydrobromide Tablets Product Portfolio
6.5.5 Zydus Pharms Recent Developments/Updates
6.6 CSPC Ouyi Pharmaceutical
6.6.1 CSPC Ouyi Pharmaceutical Corporation Information
6.6.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.6.3 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.6.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.7 Brilliant Pharmaceutical
6.6.1 Brilliant Pharmaceutical Corporation Information
6.6.2 Brilliant Pharmaceutical Description and Business Overview
6.6.3 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.7.5 Brilliant Pharmaceutical Recent Developments/Updates
6.8 Chiatai Tianqing
6.8.1 Chiatai Tianqing Corporation Information
6.8.2 Chiatai Tianqing Description and Business Overview
6.8.3 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chiatai Tianqing Vortioxetine Hydrobromide Tablets Product Portfolio
6.8.5 Chiatai Tianqing Recent Developments/Updates
6.9 Sino Biopharmaceutical
6.9.1 Sino Biopharmaceutical Corporation Information
6.9.2 Sino Biopharmaceutical Description and Business Overview
6.9.3 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Product Portfolio
6.9.5 Sino Biopharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vortioxetine Hydrobromide Tablets Industry Chain Analysis
7.2 Vortioxetine Hydrobromide Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vortioxetine Hydrobromide Tablets Production Mode & Process
7.4 Vortioxetine Hydrobromide Tablets Sales and Marketing
7.4.1 Vortioxetine Hydrobromide Tablets Sales Channels
7.4.2 Vortioxetine Hydrobromide Tablets Distributors
7.5 Vortioxetine Hydrobromide Tablets Customers
8 Vortioxetine Hydrobromide Tablets Market Dynamics
8.1 Vortioxetine Hydrobromide Tablets Industry Trends
8.2 Vortioxetine Hydrobromide Tablets Market Drivers
8.3 Vortioxetine Hydrobromide Tablets Market Challenges
8.4 Vortioxetine Hydrobromide Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Vortioxetine Hydrobromide Tablets Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global Vortioxetine Hydrobromide Tablets Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global Vortioxetine Hydrobromide Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vortioxetine Hydrobromide Tablets Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vortioxetine Hydrobromide Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vortioxetine Hydrobromide Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vortioxetine Hydrobromide Tablets Average Price (US$/g) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vortioxetine Hydrobromide Tablets, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Vortioxetine Hydrobromide Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vortioxetine Hydrobromide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vortioxetine Hydrobromide Tablets as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vortioxetine Hydrobromide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vortioxetine Hydrobromide Tablets Sales by Region (2020-2025) & (Kg)
Table 18. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Vortioxetine Hydrobromide Tablets Sales by Region (2026-2031) & (Kg)
Table 20. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Vortioxetine Hydrobromide Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Vortioxetine Hydrobromide Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Vortioxetine Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vortioxetine Hydrobromide Tablets Sales by Country (2020-2025) & (Kg)
Table 27. North America Vortioxetine Hydrobromide Tablets Sales by Country (2026-2031) & (Kg)
Table 28. North America Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vortioxetine Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vortioxetine Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vortioxetine Hydrobromide Tablets Sales by Country (2020-2025) & (Kg)
Table 32. Europe Vortioxetine Hydrobromide Tablets Sales by Country (2026-2031) & (Kg)
Table 33. Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vortioxetine Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vortioxetine Hydrobromide Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vortioxetine Hydrobromide Tablets Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Vortioxetine Hydrobromide Tablets Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Vortioxetine Hydrobromide Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vortioxetine Hydrobromide Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vortioxetine Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Vortioxetine Hydrobromide Tablets Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vortioxetine Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Vortioxetine Hydrobromide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa Vortioxetine Hydrobromide Tablets Sales by Country (2020-2025) & (Kg)
Table 47. Middle East & Africa Vortioxetine Hydrobromide Tablets Sales by Country (2026-2031) & (Kg)
Table 48. Middle East & Africa Vortioxetine Hydrobromide Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Vortioxetine Hydrobromide Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vortioxetine Hydrobromide Tablets Sales (Kg) by Type (2020-2025)
Table 51. Global Vortioxetine Hydrobromide Tablets Sales (Kg) by Type (2026-2031)
Table 52. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Vortioxetine Hydrobromide Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vortioxetine Hydrobromide Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Vortioxetine Hydrobromide Tablets Price (US$/g) by Type (2020-2025)
Table 59. Global Vortioxetine Hydrobromide Tablets Price (US$/g) by Type (2026-2031)
Table 60. Global Vortioxetine Hydrobromide Tablets Sales (Kg) by Application (2020-2025)
Table 61. Global Vortioxetine Hydrobromide Tablets Sales (Kg) by Application (2026-2031)
Table 62. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Vortioxetine Hydrobromide Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Vortioxetine Hydrobromide Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vortioxetine Hydrobromide Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Vortioxetine Hydrobromide Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Vortioxetine Hydrobromide Tablets Price (US$/g) by Application (2020-2025)
Table 69. Global Vortioxetine Hydrobromide Tablets Price (US$/g) by Application (2026-2031)
Table 70. H.Lundbeck A/S Corporation Information
Table 71. H.Lundbeck A/S Description and Business Overview
Table 72. H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 73. H.Lundbeck A/S Vortioxetine Hydrobromide Tablets Product
Table 74. H.Lundbeck A/S Recent Developments/Updates
Table 75. Kanghong Pharmaceutical Corporation Information
Table 76. Kanghong Pharmaceutical Description and Business Overview
Table 77. Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 78. Kanghong Pharmaceutical Vortioxetine Hydrobromide Tablets Product
Table 79. Kanghong Pharmaceutical Recent Developments/Updates
Table 80. Takeda Pharmaceuticals USA Corporation Information
Table 81. Takeda Pharmaceuticals USA Description and Business Overview
Table 82. Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 83. Takeda Pharmaceuticals USA Vortioxetine Hydrobromide Tablets Product
Table 84. Takeda Pharmaceuticals USA Recent Developments/Updates
Table 85. Takeda Pharmaceutical Corporation Information
Table 86. Takeda Pharmaceutical Description and Business Overview
Table 87. Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 88. Takeda Pharmaceutical Vortioxetine Hydrobromide Tablets Product
Table 89. Takeda Pharmaceutical Recent Developments/Updates
Table 90. Zydus Pharms Corporation Information
Table 91. Zydus Pharms Description and Business Overview
Table 92. Zydus Pharms Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. Zydus Pharms Vortioxetine Hydrobromide Tablets Product
Table 94. Zydus Pharms Recent Developments/Updates
Table 95. CSPC Ouyi Pharmaceutical Corporation Information
Table 96. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 97. CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 98. CSPC Ouyi Pharmaceutical Vortioxetine Hydrobromide Tablets Product
Table 99. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 100. Brilliant Pharmaceutical Corporation Information
Table 101. Brilliant Pharmaceutical Description and Business Overview
Table 102. Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 103. Brilliant Pharmaceutical Vortioxetine Hydrobromide Tablets Product
Table 104. Brilliant Pharmaceutical Recent Developments/Updates
Table 105. Chiatai Tianqing Corporation Information
Table 106. Chiatai Tianqing Description and Business Overview
Table 107. Chiatai Tianqing Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 108. Chiatai Tianqing Vortioxetine Hydrobromide Tablets Product
Table 109. Chiatai Tianqing Recent Developments/Updates
Table 110. Sino Biopharmaceutical Corporation Information
Table 111. Sino Biopharmaceutical Description and Business Overview
Table 112. Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 113. Sino Biopharmaceutical Vortioxetine Hydrobromide Tablets Product
Table 114. Sino Biopharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Vortioxetine Hydrobromide Tablets Distributors List
Table 118. Vortioxetine Hydrobromide Tablets Customers List
Table 119. Vortioxetine Hydrobromide Tablets Market Trends
Table 120. Vortioxetine Hydrobromide Tablets Market Drivers
Table 121. Vortioxetine Hydrobromide Tablets Market Challenges
Table 122. Vortioxetine Hydrobromide Tablets Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vortioxetine Hydrobromide Tablets
Figure 2. Global Vortioxetine Hydrobromide Tablets Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global Vortioxetine Hydrobromide Tablets Market Share by Type in 2024 & 2031
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. 20mg Product Picture
Figure 7. Global Vortioxetine Hydrobromide Tablets Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 8. Global Vortioxetine Hydrobromide Tablets Market Share by Application in 2024 & 2031
Figure 9. Antidepressants
Figure 10. Anxiolytics
Figure 11. Global Vortioxetine Hydrobromide Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vortioxetine Hydrobromide Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Vortioxetine Hydrobromide Tablets Sales (2020-2031) & (Kg)
Figure 14. Global Vortioxetine Hydrobromide Tablets Average Price (US$/g) & (2020-2031)
Figure 15. Vortioxetine Hydrobromide Tablets Report Years Considered
Figure 16. Vortioxetine Hydrobromide Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Vortioxetine Hydrobromide Tablets Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Vortioxetine Hydrobromide Tablets Players: Market Share by Revenue in 2024
Figure 19. Vortioxetine Hydrobromide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 20. Global Vortioxetine Hydrobromide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Vortioxetine Hydrobromide Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Vortioxetine Hydrobromide Tablets Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Vortioxetine Hydrobromide Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Vortioxetine Hydrobromide Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Vortioxetine Hydrobromide Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Vortioxetine Hydrobromide Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Vortioxetine Hydrobromide Tablets Sales Market Share by Country (2020-2031)
Figure 45. Latin America Vortioxetine Hydrobromide Tablets Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Vortioxetine Hydrobromide Tablets Sales Market Share by Country (2020-2031)
Figure 50. Middle East & Africa Vortioxetine Hydrobromide Tablets Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Vortioxetine Hydrobromide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Vortioxetine Hydrobromide Tablets by Type (2020-2031)
Figure 55. Global Revenue Market Share of Vortioxetine Hydrobromide Tablets by Type (2020-2031)
Figure 56. Global Vortioxetine Hydrobromide Tablets Price (US$/g) by Type (2020-2031)
Figure 57. Global Sales Market Share of Vortioxetine Hydrobromide Tablets by Application (2020-2031)
Figure 58. Global Revenue Market Share of Vortioxetine Hydrobromide Tablets by Application (2020-2031)
Figure 59. Global Vortioxetine Hydrobromide Tablets Price (US$/g) by Application (2020-2031)
Figure 60. Vortioxetine Hydrobromide Tablets Value Chain
Figure 61. Vortioxetine Hydrobromide Tablets Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

※参考情報

ボルチオキセチン臭化水素酸塩錠は、抗うつ薬として広く用いられている医薬品です。この薬は主に大うつ病性障害の治療に使用され、神経伝達物質であるセロトニンに作用することによって、気分の改善を図ることを目的としています。ボルチオキセチンは、いくつかのメカニズムを介してセロトニンシステムに影響を与え、抗うつ作用を発揮します。

ボルチオキセチンの特徴としては、セロトニンの再取り込み阻害作用に加えて、セロトニン受容体に対する拮抗作用および部分作動作用を持つことが挙げられます。具体的には、5-HT1A受容体に対して部分作動薬として働き、5-HT3受容体に対しては拮抗薬としての作用を示します。このような多様な作用メカニズムにより、ボルチオキセチンは他の抗うつ薬とは一線を画し、効果的かつ多面的なアプローチが可能です。

ボルチオキセチンの使用におけるメリットには、副作用の軽減や、認知機能の改善が含まれます。一般的な抗うつ薬には、しばしば抗コリン作用に関連する副作用や、体重増加、性機能障害といった問題が見られますが、ボルチオキセチンにおいてはそれらの副作用が比較的軽減されることが多いと報告されています。また、患者の中にはうつ病に伴う認知機能の低下を訴える方が多くいますが、ボルチオキセチンはこの認知機能に対する改善効果も期待されています。

ボルチオキセチンの服用方法については、通常、成人には1日1回の服用が推奨されます。初めて服用する患者には、低用量から始め、徐々に効果や副作用を見ながら用量を調整することが一般的です。また、服用を中止する際には、急に中止するのではなく、専門医の指導のもとで次第に減量することが推奨されます。これは、急な中断が再発を引き起こす可能性があるためです。

ボルチオキセチンは、他の多くの薬剤と同様に、副作用があることも留意が必要です。一般的に報告されている副作用には、吐き気、下痢、めまい、眠気、錯乱などがあります。これらの副作用は、個人差が大きく、すべての患者に影響を及ぼすわけではありませんが、特に新たにボルチオキセチンを投与される患者にとっては最初の数週間に不快感を感じる場合があります。副作用が強く出る場合には、医師に相談することが重要です。

さらに、ボルチオキセチンは他の薬剤との相互作用にも注意が必要です。特に、セロトニン症候群という重篤な状態を引き起こすおそれがあるため、MAO阻害剤などセロトニンに影響を与える薬剤との併用は避ける必要があります。また、抗うつ薬を服用している患者は、投与された薬剤について十分に理解し、意識的に服用することが求められます。

ボルチオキセチンの用途は主にうつ病の治療に留まらず、最近では不安障害や強迫性障害など他の精神疾患においてもその効果が研究されています。今後の研究・臨床試験によって、ボルチオキセチンの更なる利用可能性が探求されることが期待されています。

加えて、ボルチオキセチンに関連する技術や研究も進展しています。最近では、個別化医療の推進に伴い、患者の遺伝的背景や質的な情報を基に、抗うつ薬の選択や効果判定を行う研究が行われています。ボルチオキセチンにおいても、個々の患者に適した用量や投与計画を立てることが期待されています。

新たな精神障害の治療の可能性としても注目されており、ボルチオキセチンの特性を生かした治療法の開発が進んでいます。また、臨床現場での実績が増えるにつれて、ボルチオキセチンに対する理解も深まりつつあります。これに伴い、医療従事者や患者に対しても正確な情報提供が求められ、教育の重要性が認識されています。

ボルチオキセチンは、その多様な薬理作用と新しい治療アプローチにより、うつ病治療の新たな選択肢を提供します。その効果を最大限に活かすためには、専門医との密接な連携が重要であり、患者自身も積極的に治療に参加することが望ましいです。今後の研究や臨床データの蓄積により、ボルチオキセチンの位置づけや治療戦略がさらに洗練され、より多くの患者に対する恩恵がもたらされることを期待しています。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ドセタキセル注射液の世界市場2025年：10mg/ml、20mg/ml、40mg/ml、その他
  • ベンダゾール錠のグローバル市場2023：20mg/錠、10mg/錠
  • オキシコドン塩酸徐放性錠剤のグローバル市場2023：10mg、20mg、その他
  • リバーロキサバン錠のグローバル市場2023：2.5mg/錠、10mg/錠、15mg/錠、20mg/錠
  • 一硝酸イソソルビド錠剤の世界市場2023-2029：10mg、20mg、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8924 )"ボルチオキセチン臭化水素酸塩錠の世界市場2025年：5mg、10mg、20mg" (英文：Global Vortioxetine Hydrobromide Tablets Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。